The Biden administration released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
Yes. I think they looked at the top prescription drug costs, including volume, and took aim at the ones where discounts would save the most.